The Coordination of Prostaglandin E2 Production by Sphingosine-1-phosphate and Ceramide-1-phosphate
Authors:
- Kazuyuki KitataniKazuyuki Kitatani
- Charles E ChalfantCCCharles E Chalfant
- Tarek A TahaTTTarek A Taha
- Toshihiko KawamoriTKToshihiko Kawamori
- Jacek BielawskiJBJacek Bielawski
- Lina M. ObeidLOLina M. Obeid
- Yusuf A HannunYHYusuf A Hannun
- 1 August 2005
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 68 (2) , 330-335
Abstract
The ability of pro-inflammatory cytokines such as interleukin-1β (IL-1β) to induce the major inflammatory mediator prostaglandin (PG) E2 depends on the activation of two rate-limiting enzymes, phospholipase A2 (PLA2) and cyclooxygenase 2 (COX-2). PLA2 acts to generate arachidonic acid, which serves as the precursor substrate for COX-2 in the metabolic pathway leading to PGE2 production. However, less is known about the mechanisms that coordinate the regulation of these two enzymes. We have provided prior evidence that sphingosine kinase 1 and its bioactive lipid product sphingosine-1-phosphate (S1P) mediate the effects of cytokines on COX-2 induction, whereas ceramide kinase and its distinct product, ceramide-1-phosphate (C1P), are required for the activation and translocation of cPLA2 (FASEB J 17:1411-1421. 2003; J Biol Chem 278:38206-38213, 2003; J Biol Chem 279:11320-11326, 2004). Herein, we show that these two pathways are independent but coordinated, resulting in synergistic induction of PGE2. Moreover, the combination of both S1P and C1P recapitulates the temporal and spatial activation of cPLA2 and with COX-2 seen IL-1β. Taken together, the results provide, for the first time, a mechanism that assures the coordinate expression and activation in time and space of COX-2 and cPLA2, assuring maximal production of PGE2.Keywords
This publication has 12 references indexed in Scilit:
- Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1β and TNF-α induced production of inflammatory mediatorsCellular Signalling, 2005
- The role of sphingosine and ceramide kinases in inflammatory responsesImmunology Letters, 2005
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Ceramide 1-Phosphate Is a Direct Activator of Cytosolic Phospholipase A2Journal of Biological Chemistry, 2004
- Ceramide Kinase Mediates Cytokine- and Calcium Ionophore-induced Arachidonic Acid ReleaseJournal of Biological Chemistry, 2003
- The sphingosine kinase 1/sphingosine‐1‐phosphate pathway mediates COX‐2 induction and PGE 2 production in response to TNF‐αThe FASEB Journal, 2003
- Cyclooxygenase-2—10 Years LaterThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Localization and regulation of cytosolic phospholipase A2Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactionsAntimicrobial Agents and Chemotherapy, 1993
- cPLA2 is phosphorylated and activated by MAP kinaseCell, 1993